(Q38913170)

7 September 2017

title

Functional and clinical evidence that TAZ is a candidate oncogene in hepatocellular carcinoma (English)

1 reference

7 September 2017

Yan Guo

1

1 reference

7 September 2017

Qiao Pan

2

1 reference

7 September 2017

Jing Zhang

3

1 reference

7 September 2017

Xinyuan Xu

4

1 reference

7 September 2017

Xiping Liu

5

1 reference

7 September 2017

Qinhao Wang

6

1 reference

7 September 2017

Ru Yi

7

1 reference

7 September 2017

Xiaobo Xie

8

1 reference

7 September 2017

Libo Yao

9

1 reference

7 September 2017

Wenchao Liu

10

1 reference

7 September 2017

Lan Shen

11

1 reference

7 September 2017

language of work or name

1 reference

3 February 2015

1 reference

Journal of Cellular Biochemistry

7 September 2017

published in

1 reference

7 September 2017

volume

116

1 reference

7 September 2017

issue

11

1 reference

7 September 2017

page(s)

2465-2475

1 reference

Akt phosphorylates the Yes-associated protein, YAP, to induce interaction with 14-3-3 and attenuation of p73-mediated apoptosis

7 September 2017

cites work

1 reference

Hepatocellular carcinoma of the liver

21 January 2018

1 reference

The Hippo pathway in biological control and cancer development

21 January 2018

1 reference

TEADs mediate nuclear retention of TAZ to promote oncogenic transformation

21 January 2018

1 reference

Human Kruppel-like factor 5 is a target of the E3 ubiquitin ligase WWP1 for proteolysis in epithelial cells

21 January 2018

1 reference

Connective tissue growth factor (CTGF) and cancer progression

21 January 2018

1 reference

The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells

21 January 2018

1 reference

Identification of metastasis candidate proteins among HCC cell lines by comparative proteome and biological function analysis of S100A4 in metastasis in vitro

21 January 2018

1 reference

TAZ/WWTR1 is overexpressed in papillary thyroid carcinoma.

21 January 2018

1 reference

Elucidation of a universal size-control mechanism in Drosophila and mammals

21 January 2018

1 reference

Acetylation of KLF5 alters the assembly of p15 transcription factors in transforming growth factor-beta-mediated induction in epithelial cells

21 January 2018

1 reference

TAZ, a transcriptional modulator of mesenchymal stem cell differentiation

21 January 2018

1 reference

Glomerulocystic kidney disease in mice with a targeted inactivation of Wwtr1

21 January 2018

1 reference

TAZ: a novel transcriptional co-activator regulated by interactions with 14-3-3 and PDZ domain proteins

21 January 2018

1 reference

Adjuvant therapy after curative treatment for hepatocellular carcinoma

21 January 2018

1 reference

TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the hippo pathway

21 January 2018

1 reference

Local-regional treatment of hepatocellular carcinoma

21 January 2018

1 reference

The role of YAP transcription coactivator in regulating stem cell self-renewal and differentiation

21 January 2018

1 reference

MicroRNA-375 targets Hippo-signaling effector YAP in liver cancer and inhibits tumor properties.

21 January 2018

1 reference

Targeting YAP and Hippo signaling pathway in liver cancer

21 January 2018

1 reference

Proteomics of hepatocellular carcinoma in Chinese patients

21 January 2018

1 reference

Multiple renal cysts, urinary concentration defects, and pulmonary emphysematous changes in mice lacking TAZ

21 January 2018

1 reference

Cancer biomarkers for hepatocellular carcinomas: from traditional markers to recent topics

21 January 2018

1 reference

Haploinsufficiency of Krüppel-like factor 5 rescues the tumor-initiating effect of the Apc(Min) mutation in the intestine

21 January 2018

1 reference

A WW domain protein TAZ is a critical coactivator for TBX5, a transcription factor implicated in Holt-Oram syndrome

21 January 2018

1 reference

Transcriptional activity of Pax3 is co-activated by TAZ

21 January 2018

1 reference

Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon

21 January 2018

1 reference

The hippo signaling pathway in development and cancer

21 January 2018

1 reference

Expression of Yes-associated protein in common solid tumors

21 January 2018

1 reference

Molecular targeted therapy for hepatocellular carcinoma in the current and potential next strategies

21 January 2018

1 reference

Blood lipid mediator sphingosine 1-phosphate potently stimulates platelet-derived growth factor-A and -B chain expression through S1P1-Gi-Ras-MAPK-dependent induction of Kruppel-like factor 5

21 January 2018

1 reference

Hepatocellular carcinoma and liver transplantation

21 January 2018

1 reference

Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma

21 January 2018

1 reference

Yes-associated protein (YAP) functions as a tumor suppressor in breast.

21 January 2018

1 reference

Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach

21 January 2018

1 reference

TEAD transcription factors mediate the function of TAZ in cell growth and epithelial-mesenchymal transition

21 January 2018

1 reference

The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version

21 January 2018

1 reference

TAZ antagonizes the WWP1-mediated KLF5 degradation and promotes breast cell proliferation and tumorigenesis

21 January 2018

1 reference

Krüppel-like factor 5 promotes breast cell proliferation partially through upregulating the transcription of fibroblast growth factor binding protein 1.

21 January 2018

1 reference

TAZ is a novel oncogene in non-small cell lung cancer.

21 January 2018

1 reference

Liver transplantation for hepatocellular carcinoma: Hangzhou experiences

21 January 2018

1 reference

3 January 2024

https://opencitations.net/index/api/v1/citations/10.1097/TP.0B013E31816B67E4

Identifiers

DOI

10.1002/JCB.25117

1 reference

7 September 2017

1 reference